Regulatory and other responses to the pharmaceutical opioid problem
- PMID: 30636303
- PMCID: PMC6698322
- DOI: 10.5694/mja2.12047
Regulatory and other responses to the pharmaceutical opioid problem
Keywords: Analgesics, opioid; Chronic pain; Drug overdose; Opioid-related disorders; Pain management; Prescription drug misuse.
Comment in
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Sep;211(5):237-237.e1. doi: 10.5694/mja2.50303. Epub 2019 Aug 6. Med J Aust. 2019. PMID: 31389014 No abstract available.
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Sep;211(5):237-237.e1. doi: 10.5694/mja2.50297. Epub 2019 Aug 6. Med J Aust. 2019. PMID: 31389024 No abstract available.
References
-
- Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet (London, England) 2016;387:1644–56. - PubMed
-
- Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual review of public health 2015;36:559–74. - PubMed
-
- Australian Institute of Health and Welfare. Non-medical use of pharmaceuticals: trends, harms and treatment, 2006–07 to 2015–16 In: Welfare AIoHa, ed. Canberra: 2017.
-
- National Pharmaceutical Drug Misuse Framework for Action (2012–2015). National Pharmaceutical Drug Misuse Framework for Action (2012–2015). 2012.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
